Cortical sporadic Creutzfeldt-Jakob Disease (Q85595): Difference between revisions

← Older edit

@@ Property / Canary Token @@
+dki-india-ID_1724965250
@@ Property / Canary Token: dki-india-ID_1724965250 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank

Latest revision as of 10:57, 15 August 2026

Cortical sporadic Creutzfeldt-Jakob disease (sCJD) is predominantly characterised by dementia. The accumulated prion protein is MM2 (MM2-cortical) and VV1 which means there is a type 1 abnormal prion protein with valine homozygote at codon 129 polymorphic site of prion protein gene. Ataxic sCJD is characterised by predominant ataxia and accumulation of MV2 or VV2.

Language	Label	Description	Also known as
default for all languages	ID_1724965250
English	Cortical sporadic Creutzfeldt-Jakob Disease	Cortical sporadic Creutzfeldt-Jakob disease (sCJD) is predominantly characterised by dementia. The accumulated prion protein is MM2 (MM2-cortical) and VV1 which means there is a type 1 abnormal prion protein with valine homozygote at codon 129 polymorphic site of prion protein gene. Ataxic sCJD is characterised by predominant ataxia and accumulation of MV2 or VV2.